Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors
| Status: | Archived |
|---|---|
| Conditions: | Skin Cancer, Cancer, Cancer, Brain Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2009 |
A Phase I, Multicenter, Open-label, Dose-escalation Study of Oral LDE225 in Patients With Advanced Solid Tumors
This first-in-human dose-escalation study is to characterize the safety, tolerability,
pharmacokinetics and pharmacodynamics of LDE225 given orally on a daily dosing schedule in
patients with advanced solid tumors.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials